These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4401326)

  • 1. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
    Ng KY; Colburn RW; Kopin IJ
    Nature; 1971 Apr; 230(5292):331-2. PubMed ID: 5549411
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of catechol-O-methyl transferase by catechols and polyphenols.
    Baldessarini RJ; Greiner E
    Biochem Pharmacol; 1973 Jan; 22(2):247-56. PubMed ID: 4763253
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of L-dopa after inhibition of catechol-O-methyl transferase.
    Baldessarini RJ; Chace KV
    Eur J Pharmacol; 1972 Jan; 17(1):163-6. PubMed ID: 5016575
    [No Abstract]   [Full Text] [Related]  

  • 5. L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart.
    Landsberg L
    Biochem Pharmacol; 1971 Dec; 20(12):3542-7. PubMed ID: 5132898
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I; Bartholini G; Tissot R; Fletscher A
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of catechol O methyltransferase inhibitors on the distribution of norepinephrine-H 3 in rats].
    Rapin JR; Caillard RC; Cohen Y; Valette G
    C R Seances Soc Biol Fil; 1971; 165(1):60-4. PubMed ID: 4257753
    [No Abstract]   [Full Text] [Related]  

  • 8. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1970 Aug; 22(8):553-60. PubMed ID: 4394527
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of various agents on the pressor response to dopa in the anesthetized dog.
    Pruss TP; McGill JS
    Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043
    [No Abstract]   [Full Text] [Related]  

  • 10. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 11. Catechol O-methyltransferase. IV. Factors affecting m- and p-methylation of substituted catechols.
    Creveling CR; Morris N; Shimizu H; Ong HH; Daly J
    Mol Pharmacol; 1972 Jul; 8(4):398-409. PubMed ID: 4340872
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 13. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
    Butcher L; Engel J; Fuxe K
    J Pharm Pharmacol; 1970 Apr; 22(4):313-6. PubMed ID: 4392579
    [No Abstract]   [Full Text] [Related]  

  • 14. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
    Ribéreau-Gayon G; Palfreyman MG; Zraïka M; Wagner J; Jung MJ
    Biochem Pharmacol; 1980 Sep; 29(18):2465-9. PubMed ID: 7426053
    [No Abstract]   [Full Text] [Related]  

  • 15. The action of L(-)-dopa on baroreflexes in Parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Sci; 1972 Dec; 43(6):851-9. PubMed ID: 4646277
    [No Abstract]   [Full Text] [Related]  

  • 16. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
    [No Abstract]   [Full Text] [Related]  

  • 19. Block of cerebral actions of L-dopa with methyl receptor substances.
    Cotzias GC; Tang L; Ginos JZ; Nicholson AR; Papavasiliou PS
    Nature; 1971 Jun; 231(5304):533-5. PubMed ID: 4934569
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.